semaglutide week 2 no weight loss JOURNEY *week 2* // Food guilt (let's talk about it), finding balance + down 8 lbs! 7 Reasons You Aren't Losing

Key Takeaways Cagrilintide is a long-acting amylin analogue with clinical trial doses ranging from 0.3 mg to 4.5 mg weekly, while retatrutide is a triple agonist studied at 4 mg, 8 mg, and 12 mg weekly doses No published clinical trials currently exist evaluating the cagrilintide dosage with retatrutide combination, making any combined use experimental and off-label Both peptides work through different mechanismscagrilintide activates amylin receptors while retatrutide targets GIP, GLP-1, and glucagon receptorssuggesting potential complementary effects Gastrointestinal side effects (nausea, vomiting) occur in 60-80% of participants at higher doses for both compounds, raising concerns about additive effects when combined Proper dose escalation protocols spanning 8-20 weeks are critical for tolerability and adherence in peptide-based metabolic therapies Understanding Cagrilintide: Mechanism and Dosage Fundamentals What Is Cagrilintide

I think we often get questions from family members about their own health because of exactly what Dr

#GLP1 #Ozempic #Mounjaro #DiabetesCare #MedicationSideEffects #healthtips | Luis Carlos Ortiz

The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment

In addition to alcohol-related gastrointestinal chronic conditions like peptic ulcer disease and esophagitis, acute alcohol intoxication may lead to acute esophagitis and gastritis with severe nausea and vomiting and in some cases life-threating complications due to e.g., bleeding and Mallory-Weiss syndrome (tear or laceration of the gastroesophageal junction) [42]